* Sotera Health Co SHC.OQ SHC.O is expected to show a
rise in
quarterly revenue when it reports results on May 2 for the
period ending March 31 2024
* The Broadview Heights Ohio-based company is expected to
report
a 10.9% increase in revenue to $244.557 million from $220.59
million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
* LSEG's mean analyst estimate for Sotera Health Co is for
earnings of 13 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months.
* Wall Street's median 12-month price target for Sotera
Health Co
is $16.00, above its last closing price of $11.38.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 0.26 0.26 0.26 Met 0.9
Sep. 30 2023 0.20 0.20 0.21 Beat 6.2
Jun. 30 2023 0.17 0.18 0.21 Beat 19.9
Mar. 31 2023 0.14 0.14 0.13 Missed -4.5
Jan. 0.22 0.22 0.25 Beat 14.1
1 0001
Sep. 30 2022 0.22 0.22 0.23 Beat 2.8
Jun. 30 2022 0.24 0.24 0.27 Beat 11.3
Mar. 31 2022 0.19 0.19 0.22 Beat 13.6
This summary was machine generated April 30 at 14:01 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)